Articolul precedent |
Articolul urmator |
307 0 |
SM ISO690:2012 VESELOVSKAIA, Ana, GAMANIUC, Marina. Leziuni hepatice la pacienții cu infecţia COVID-19. In: Congresul consacrat aniversării a 75-a de la fondarea Universității de Stat de Medicină şi Farmacie „Nicolae Testemiţanu”, 21-23 octombrie 2020, Chişinău. Chişinău: USMF, 2020, p. 73. |
EXPORT metadate: Google Scholar Crossref CERIF DataCite Dublin Core |
Congresul consacrat aniversării a 75-a de la fondarea Universității de Stat de Medicină şi Farmacie „Nicolae Testemiţanu” 2020 | ||||||
Congresul "Congresul consacrat aniversării a 75-a de la fondarea Universității de Stat de Medicină şi Farmacie „Nicolae Testemiţanu”" Chişinău, Moldova, 21-23 octombrie 2020 | ||||||
|
||||||
Pag. 73-73 | ||||||
|
||||||
Descarcă PDF | ||||||
Rezumat | ||||||
Background. In December 2019, a novel coronavirus, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), broke out in the Chinese province of Wuhan and rapidly infected hundreds of thousands of people worldwide. Infected patients mostly exhibit general signs of pneumonia. Objective of the study. Study of literature data on liver biomarkers in patients with COVID-19 infection that could provide information about liver damage Material and Methods. Literature review study using database PubMed has been performed. In the search process keywords –„COVID-19” , „liver damage” and „biomarkers” have been used. Results. Lactate dehydrogenase, aspartate aminotransferase (AST) and alanine aminotransferase (ALT) are often elevated in COVID-19 patients, indicating liver damage. Recent reports point to the fact that liver injury, by means of increased aminotransferase levels, more frequently occurred in severe COVID-19 cases compared to patients with mild symptoms. Conclusion. Further studies are needed on the impact of SARS-CoV-2 virus on liver cells. |
||||||
Cuvinte-cheie COVID-19, liver damage, biomarkers, COVID-19, leziunile hepatice, biomarkeri |
||||||
|